171 related articles for article (PubMed ID: 11263766)
1. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.
Merkesdal S; Ruof J; Schöffski O; Bernitt K; Zeidler H; Mau W
Arthritis Rheum; 2001 Mar; 44(3):528-34. PubMed ID: 11263766
[TBL] [Abstract][Full Text] [Related]
2. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
Li X; Gignac MA; Anis AH
Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
4. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
6. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
7. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.
Verstappen SM; Boonen A; Verkleij H; Bijlsma JW; Buskens E; Jacobs JW;
Ann Rheum Dis; 2005 Dec; 64(12):1754-60. PubMed ID: 15860510
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
[TBL] [Abstract][Full Text] [Related]
9. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
[TBL] [Abstract][Full Text] [Related]
10. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
[TBL] [Abstract][Full Text] [Related]
12. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
13. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
J Rheumatol; 1997 Jan; 24(1):43-8. PubMed ID: 9002009
[TBL] [Abstract][Full Text] [Related]
14. [Indicators of work incapacity in the first year of chronic polyarthritis].
Mau W; Bornmann M; Weber H
Z Rheumatol; 1996; 55(4):233-40. PubMed ID: 8967183
[TBL] [Abstract][Full Text] [Related]
15. 28-Joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project.
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2011 Jul; 50(7):1259-67. PubMed ID: 21292734
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
Osiri M; Maetzel A; Tugwell P
J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
[TBL] [Abstract][Full Text] [Related]
17. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
[TBL] [Abstract][Full Text] [Related]
18. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
[TBL] [Abstract][Full Text] [Related]
19. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
20. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
